Experienced in Fibrosarcoma

Dr. Christopher J. Anker

Radiology | Radiation Oncology
University Of Vermont Medical Center Inc
160 Allen St, 
Rutland, VT 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in Fibrosarcoma
University Of Vermont Medical Center Inc
160 Allen St, 
Rutland, VT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Anker is a Radiologist and a Radiation Oncologist in Rutland, Vermont. Dr. Anker is rated as an Experienced provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Lung Cancer, Anal Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Liver Embolization. Dr. Anker is currently accepting new patients.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiology
Radiation Oncology
Licenses
Therapeutic Radiology in UT
Hospital Affiliations
Univ. Of Vermont - Fletcher Allen Health Care
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

UNIVERSITY OF VERMONT MEDICAL CENTER INC
160 Allen St, Rutland, VT 05701
Other Locations
UNIVERSITY OF VERMONT MEDICAL CENTER INC
111 Colchester Ave, Burlington, VT 05401
UNIVERSITY OF VERMONT MEDICAL CENTER INC
1 S Prospect St, Burlington, VT 05401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Procedure, Biological
Study Drugs: Ipilimumab, Nivolumab, Sargramostim
Study Phase: Phase 2/Phase 3
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma
Enrollment Status: Completed
Publish Date: October 10, 2025
Intervention Type: Radiation, Drug
Study Drug: Sorafenib Tosylate
Study Phase: Phase 3
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
A Phase III Randomized Trial Comparing Physician/Patient Choice of Either High Dose Interferon or Ipilimumab to MK-3475 (Pembrolizumab) in Patients With High Risk Resected Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Procedure, Biological
Study Drugs: Ipilimumab, Pembrolizumab, Recombinant Interferon Alfa-2b
Study Phase: Phase 3
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2025
Intervention Type: Other, Drug, Radiation, Procedure
Study Drugs: Atezolizumab, Carboplatin, Cisplatin, Etoposide
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: April 24, 2024
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: August 28, 2019
Intervention Type: Radiation
Study Phase: Phase 3
View 7 Less Clinical Trials

64 Total Publications

Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer: Systematic Review and Guidelines.
Executive Summary of the American Radium Society Appropriate Use Criteria for the Use of Esophageal Stents in Patients With Esophageal Cancer: Systematic Review and Guidelines.
Journal: American journal of clinical oncology
Published: June 25, 2025
Similar Doctors
Distinguished in Fibrosarcoma
Dr. Thomas F. Delaney
Radiation Oncology | Radiology
Distinguished in Fibrosarcoma
Dr. Thomas F. Delaney
Radiation Oncology | Radiology

Dartmouth-Hitchcock Clinic

53 Fairview St, 
Brattleboro, VT 
 (55.9 miles away)
802-257-5000
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Delaney is a Radiation Oncologist and a Radiologist in Brattleboro, Vermont. Dr. Delaney has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Chordoma, Bone Tumor, Alveolar Soft Part Sarcoma, and Pancreaticoduodenectomy. Dr. Delaney is currently accepting new patients.

Experienced in Fibrosarcoma
Dr. Nataniel H. Lester-Coll
Radiation Oncology | Radiology
Experienced in Fibrosarcoma
Dr. Nataniel H. Lester-Coll
Radiation Oncology | Radiology

University Of Vermont Medical Center Inc

111 Colchester Ave, 
Burlington, VT 
 (62.0 miles away)
802-847-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nataniel Lester-Coll is a Radiation Oncologist and a Radiologist in Burlington, Vermont. Dr. Lester-Coll is rated as a Distinguished provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Familial Prostate Cancer, Lung Cancer, Small Cell Lung Cancer (SCLC), and Prostate Cancer. Dr. Lester-Coll is currently accepting new patients.

Experienced in Fibrosarcoma
Dr. Alex H. Frank
Radiation Oncology
Experienced in Fibrosarcoma
Dr. Alex H. Frank
Radiation Oncology

Northeastern Radiation Oncology

100 Park St, 
Glens Falls, NY 
 (40.1 miles away)
518-926-6670
Languages Spoken:
English
See accepted insurances

Alex Frank is a Radiation Oncologist in Glens Falls, New York. Dr. Frank is rated as an Advanced provider by MediFind in the treatment of Fibrosarcoma. His top areas of expertise are Familial Prostate Cancer, Laryngeal Cancer, Pleuropulmonary Blastoma, and Lung Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Anker's expertise for a condition
ConditionClose
    View All 25 Advanced Conditions
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile